Wuhan More Biotechnology Co., Ltd.

Morebio was founded in 2008, with a registered capital of RMB21.4824 million. It is a high-tech enterprise specializing in R&D of new peptide drugs, and a National "Two Major" Project Construction Unit. In November 2011, it was awarded as “High-tech Enterprise” by Hubei Province. It has established the active substance research and development center of Mole Biology-Wuhan University and academician expert workstation. We have 16 national invention patents, and undertake in 2 national major new drug creation projects.  Morebio establishes the full-chain of polypeptide drug R&D technology platform: polypeptide gene engineering expression (purification) platform, polypeptide drug molecular...